Cg Oncology, Inc.

This study tests whether a virus-based treatment called cretostimogene grenadenorepvec can prevent intermediate-risk bladder cancer from returning after surgery. About 367 participants will either receive the treatment or be monitored. The goal is to see if the therapy extends th…

This study tests a new treatment called cretostimogene grenadenorepvec for people with a type of bladder cancer that did not get better with standard therapy. About 190 participants will receive this virus-based therapy to see if it can shrink tumors or delay cancer from coming b…

This study tested a virus-based treatment called CG0070 for people with a high-grade type of bladder cancer that did not respond to standard therapy (BCG) and who chose not to have their bladder removed. The goal was to see if the treatment could control the cancer and reduce the…